We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
Learn about vulvar cancer spread, stages, and survival rates. Understand symptoms, diagnosis, treatment, and prevention for better health outcomes.

Vulvar cancer is a rare type of cancer that affects the outer part of a woman's genitals, known as the vulva. While it is less common than other gynecological cancers, understanding its progression, stages, and survival rates is crucial for early detection and effective treatment, especially for women in India. This blog post aims to provide clear, practical information about how vulvar cancer spreads, its different stages, and what factors influence survival rates.
The vulva is the external female genitalia, including the labia majora, labia minora, clitoris, and vaginal opening. Vulvar cancer most commonly begins in the squamous cells that make up the outer surface of the vulva. These are known as squamous cell carcinomas (SCC), accounting for the vast majority of vulvar cancer cases. However, other less common types, such as melanoma, can also occur.
The rate at which vulvar cancer spreads is highly variable and depends on several factors:
In general, vulvar cancer is considered a slow-growing cancer. However, it's essential not to underestimate its potential to spread, especially if left untreated or if it's a more aggressive subtype.
Understanding the stages of vulvar cancer helps in determining the extent of the disease and planning treatment. The staging system commonly used is the Tumor, Nodes, Metastasis (TNM) system, which describes the size of the tumor, whether it has spread to nearby lymph nodes, and whether it has metastasized (spread) to distant parts of the body.
The majority of vulvar cancer diagnoses (around 60%) occur at the localized stage. This means the cancer is confined to the vulva and has not spread to nearby lymph nodes or distant organs.
Localized vulvar cancer is often curable, especially when detected and treated early. The 5-year relative survival rate for localized cases is high, often exceeding 86%, and for Stage 1 vulvar cancer, it can be between 93-100%.
In this stage, the cancer has spread beyond the vulva to nearby structures or lymph nodes.
Regional vulvar cancer is more advanced, and the 5-year relative survival rate decreases significantly, standing at approximately 47.5%.
This is the most advanced stage, where the cancer has spread to distant organs such as the lungs, liver, or bones.
Distant metastasis is rare for vulvar cancer, especially for SCC. Treatment in this stage often focuses on managing symptoms and improving quality of life.
Survival rates are statistical estimates and can vary based on individual factors. The overall 5-year relative survival rate for vulvar cancer is nearly 70%. However, this figure is heavily influenced by the stage at diagnosis:
It's important to remember that these are statistics, and many individuals live longer and fulfilling lives after a vulvar cancer diagnosis, especially with early detection and appropriate treatment.
If you experience any symptoms, it's crucial to consult a doctor. Diagnosis typically involves:
Treatment for vulvar cancer depends on the stage, type, grade, and the patient's overall health. Common treatment modalities include:
It is important to see a doctor if you notice any persistent changes in your vulvar area, such as:
Early detection is key to successful treatment and better outcomes for vulvar cancer.
While not all cases can be prevented, certain measures can reduce the risk:
Disclaimer: This information is for educational purposes only and should not be considered medical advice. Always consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment.
Learn about potential side effects of CML treatments like TKIs, interferon, chemotherapy, and stem cell transplants. Understand what to expect and how to communicate with your doctor for effective management.
April 1, 2026

Discover essential support resources, financial aid options, and community connections for individuals navigating life with Chronic Myeloid Leukemia (CML). Find practical advice and empathetic guidance.
April 1, 2026
Explore targeted therapy for multiple myeloma. Learn how these precision treatments work, their types, potential side effects, and how they're used alongside other therapies to manage this blood cancer.
April 1, 2026